S. Blümel

Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease Patients

M. Cheetham, G. Rogler, O. Boyman, 2020, Inflammatory Intestinal Diseases.

Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard

C. Reiner, T. Kuntzen, C. Gubler, 2022, Abdominal Radiology.

Genetic risk factors predict disease progression in Crohn’s disease patients of the Swiss inflammatory bowel disease cohort

A. Franke, G. Rogler, D. Ellinghaus, 2020, Therapeutic advances in gastroenterology.

Protein Tyrosine Phosphatase Nonreceptor Type 2 Expression Does Not Correlate with Viral Load or Response to Direct-Acting Antiviral Therapy in Hepatitis C Virus Infections-Infected Patients

B. Müllhaupt, J. Mertens, M. Spalinger, 2020, Digestion.

Performance of two‐dimensional shear wave elastography and transient elastography compared to liver biopsy for staging of liver fibrosis

B. Müllhaupt, M. Scharl, C. Reiner, 2023, European journal of clinical investigation.

Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis

J. Bachofner, S. Blümel, Arnold von Eckardstein, 2024, BMC gastroenterology.